Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Gainza

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cell Reports|September 24, 2023
Rules and mechanisms governing G protein coupling selectivity of GPCRsIkuo Masuho, Ryoji Kise, Pablo Gainza, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2024
Dual ON/OFF-switch chimeric antigen receptor controlled by two clinically approved drugsGreta Maria Paola Giordano Attianese, Sailan Shui, Elisabetta Cribioli, et al.
Nature Communications|October 2, 2021
A rational blueprint for the design of chemically-controlled protein switchesSailan Shui, Pablo Gainza, Leo Scheller, et al.
Plos Computational Biology|February 10, 2022
Chiral evasion and stereospecific antifolate resistance in Staphylococcus aureusSiyu Wang, Stephanie M Reeve, Graham T Holt, et al.
Methods in Enzymology|February 21, 2013
OSPREY: protein design with ensembles, flexibility, and provable algorithmsPablo Gainza, Kyle E Roberts, Ivelin Georgiev, et al.
Nature Biomedical Engineering|April 16, 2021
Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learningDerek M Mason, Simon Friedensohn, Cédric R Weber, et al.
Journal of Computational Chemistry|October 29, 2018
OSPREY 3.0: Open-source protein redesign for you, with powerful new featuresMark A Hallen, Jeffrey W Martin, Adegoke Ojewole, et al.
Nature Biotechnology|March 5, 2020
Author Correction: A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapyGreta Giordano-Attianese, Pablo Gainza, Elise Gray-Gaillard, et al.
Nature Biotechnology|February 5, 2020
A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapyGreta Giordano-Attianese, Pablo Gainza, Elise Gray-Gaillard, et al.
Nature Communications|November 19, 2025
A degron-mimicking molecular glue drives CRBN homo-dimerization and degradationGerasimos Langousis, Pablo Gainza, Moritz Hunkeler, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cell Reports|September 24, 2023
Rules and mechanisms governing G protein coupling selectivity of GPCRsIkuo Masuho, Ryoji Kise, Pablo Gainza, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2024
Dual ON/OFF-switch chimeric antigen receptor controlled by two clinically approved drugsGreta Maria Paola Giordano Attianese, Sailan Shui, Elisabetta Cribioli, et al.
Nature Communications|October 2, 2021
A rational blueprint for the design of chemically-controlled protein switchesSailan Shui, Pablo Gainza, Leo Scheller, et al.
Plos Computational Biology|February 10, 2022
Chiral evasion and stereospecific antifolate resistance in Staphylococcus aureusSiyu Wang, Stephanie M Reeve, Graham T Holt, et al.
Methods in Enzymology|February 21, 2013
OSPREY: protein design with ensembles, flexibility, and provable algorithmsPablo Gainza, Kyle E Roberts, Ivelin Georgiev, et al.
Nature Biomedical Engineering|April 16, 2021
Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learningDerek M Mason, Simon Friedensohn, Cédric R Weber, et al.
Journal of Computational Chemistry|October 29, 2018
OSPREY 3.0: Open-source protein redesign for you, with powerful new featuresMark A Hallen, Jeffrey W Martin, Adegoke Ojewole, et al.
Nature Biotechnology|March 5, 2020
Author Correction: A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapyGreta Giordano-Attianese, Pablo Gainza, Elise Gray-Gaillard, et al.
Nature Biotechnology|February 5, 2020
A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapyGreta Giordano-Attianese, Pablo Gainza, Elise Gray-Gaillard, et al.
Nature Communications|November 19, 2025
A degron-mimicking molecular glue drives CRBN homo-dimerization and degradationGerasimos Langousis, Pablo Gainza, Moritz Hunkeler, et al.
Pageof 3